linear accelerator

直线加速器
  • 文章类型: Journal Article
    Juntendo大学医院是日本第二家开始使用线性加速器(LINAC)系统进行立体定向脑照射的医院。本报告详细介绍了立体定向辐照的历史转变,处理技术的进步,以及从开始到准腾多大学医院和准腾多尼玛医院的治疗方法的改变。医院在1993年重建时将钴的使用更改为LINAC系统。白血病的全身放射治疗大约在同一时间开始。一年后,1994年,医院使用他们的LINAC系统进行立体定向头部照射,也称为精确辐照。2005年,Juntendo大学Nerima医院开业,同年9月,当时开始使用最新型的LINAC系统进行放射治疗。这是所有Juntendo医院中第一个开始进行调强放射治疗(IMRT)和图像引导放射治疗(IGRT)的医院。2014年,JuntendoHongo医院配备了第二个用于IMRT和IGRT的LINAC系统。2021年,Juntendo大学Nerima医院的LINAC系统在使用15年后被更换。SRS的新方法是使用最新的LINAC系统开始的。在本文中,我主要介绍了我在Juntendo大学经历的SRS技术和进展。
    Juntendo University Hospital is the second hospital in Japan to start stereotactic brain irradiation using linear accelerator (LINAC) system. This report details the historical transition of stereotactic irradiation, progress of treatment technology, and change of treatment method from the beginning to the Juntendo University Hospital and Juntendo Nerima Hospital. The hospital changed the use of cobalt to the LINAC system when it was rebuilt in 1993. Total body irradiation treatment for leukemia had started around the same time. A year later, in 1994, the hospital used their LINAC systems to perform stereotactic head irradiation, otherwise known as pinpoint irradiation. In 2005, Juntendo University Nerima Hospital was opened and in September of the same year, radiation therapy using the latest model of LINAC system at that time was initiated. This was the first among all Juntendo hospitals to start intensity-modulated radiation therapy (IMRT) and image-guided radiotherapy (IGRT). In 2014, a second LINAC system for IMRT and IGRT was equipped at the Juntendo Hongo Hospital. In 2021, the LINAC systems of the Juntendo University Nerima Hospital were replaced after 15 years of usage. The new method of SRS was started using a latest LINAC systems. In this paper, I introduce the technique and progress of SRS that I have experienced mainly in Juntendo University.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    海马保护,作为脑部放射治疗的危险器官,可以保护患者的生活质量。传统上,预防性颅骨照射(PCI)已用于小细胞肺癌(SCLC)患者,因为它可以提高生存率。这项研究旨在通过使用三种不同的治疗机来发现成功的PCI并同时保护海马体的贡献参数。为此,使用三个线性加速器中的三个半弧为45名SCLC患者生成了治疗计划(LINAC;ElektaInfinity,Synergy,和Axesse;Elekta有限公司,斯德哥尔摩,瑞典)具有不同的辐射场尺寸和多叶准直器(MLC)叶片厚度特征。处方剂量为25Gy,分为10个部分。基于放射疗法肿瘤学组0933剂量约束计算海马体的阈值。计划和治疗系统模板对所有三个LINAC都是通用的。计划评估基于95%等剂量的剂量学目标覆盖率,计划的最大剂量,合格指数(CI),计划调制程度(MOD),和患者特定质量保证(QA)合格率。Infinity的平均目标覆盖率最高(97.3%),其次是Axesse(96.6%)和Synergy(95.5%)。Synergy的平均最大剂量较高(27.5Gy),其次是Infinity(27.0Gy)和Axesse(26.9Gy)。Axesse计划的最高CI(0.93),其次是Infinity(0.91)和Synergy(0.88)。与Infinity(3.07)和Axesse(3.69)相比,Synergy(2.88)的计划MOD较低。最后,患者特定的QA在所有Infinity计划中都是成功的,除了一个协同计划,在17/45Axesse计划中,正如从该处理单元的现场大小所预期的那样。基于整体性能,目标覆盖率的最有利组合,海马体保留,用LINAC获得了计划的可交付性,具有最大的田间开口和最薄的MLC叶子。
    Hippocampus protection, as an organ at risk in brain radiotherapy, might protect patients\' quality of life. Prophylactic cranial irradiation (PCI) has been used traditionally in small cell lung cancer (SCLC) patients as it increases survival. This study aimed to discover the contributing parameters for a successful PCI with simultaneous protection of the hippocampus by using three different treatment machines. For this purpose, treatment plans were generated for 45 SCLC patients using three half-arcs in three linear accelerators (LINACs; Elekta Infinity, Synergy, and Axesse; Elekta Ltd, Stockholm, Sweden) with different radiation field sizes and multileaf collimator (MLC) leaf thickness characteristics. The prescribed dose was 25 Gy in 10 fractions. Thresholds for the hippocampus were calculated based on the Radiation Therapy Oncology Group 0933 dose constraints. The planning and treatment system templates were common to all three LINACs. Plan evaluation was based on the dosimetric target coverage by the 95% isodose, the maximum dose of the plan, the conformity index (CI), the degree of plan modulation (MOD), and the patient-specific quality assurance (QA) pass rate. The mean target coverage was highest for Infinity (97.3%), followed by Axesse (96.6%) and Synergy (95.5%). The mean maximum dose was higher for Synergy (27.5 Gy), followed by Infinity (27.0 Gy) and Axesse (26.9 Gy). Axesse plans had the highest CI (0.93), followed by Infinity (0.91) and Synergy (0.88). Plan MOD was lower for Synergy (2.88) compared with Infinity (3.07) and Axesse (3.69). Finally, patient-specific QA was successful in all Infinity plans, in all but one Synergy plan, and in 17/45 Axesse plans, as was expected from the field size in that treatment unit. Based on overall performance, the most favorable combination of target coverage, hippocampus sparing, and plan deliverability was obtained with the LINAC, which has the largest field opening and thinnest MLC leaves.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    当前的在线自适应放射治疗(oART)工作流程需要专用设备。我们的目标是为C臂直线加速器开发和实施oART工作流程,该工作流程可以使用标准的临床可用工具进行。成功开发并实施了工作流。对3例接受膀胱癌姑息性放疗的患者进行了治疗,35个总部分中的33个通过锥形束计算机断层扫描(CBCT)引导的oART工作流程交付。从CBCT采集开始到光束结束的平均oART片段持续时间为24分钟。这项工作展示了如何在没有专用设备的情况下执行oART,扩大oART的可用性,适用于现有的治疗机。
    Current online adaptive radiotherapy (oART) workflows require dedicated equipment. Our aim was to develop and implement an oART workflow for a C-arm linac which can be performed using standard clinically available tools. A workflow was successfully developed and implemented. Three patients receiving palliative radiotherapy for bladder cancer were treated, with 33 of 35 total fractions being delivered with the cone-beam computed tomography (CBCT)-guided oART workflow. Average oART fraction duration was 24 min from start of CBCT acquisition to end of beam on. This work shows how oART could be performed without dedicated equipment, broadening oART availability for application at existing treatment machines.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    ANTHEM(以人为中心的医学先进技术)射频四极杆(RFQ)将采用八个同轴功率耦合器,它将通过环形天线磁耦合到设备。耦合器设计可以支持高达140千瓦的连续波操作。本文介绍了用于大功率测试的腔体的设计,主要目标是优化耦合器之间的耦合,并确保在指定的工作频率下运行。此外,本文包括通过数值模拟进行的热和结构评估。
    The ANTHEM (Advanced Technologies for Human-centered Medicine) Radio-Frequency Quadrupole (RFQ) will employ eight coaxial power couplers, which will be magnetically coupled to the device through a loop antenna. The coupler design can support up to 140 kW in continuous wave operation. This paper presents the design of the cavity used for high-power testing, with the primary objectives of both optimizing the coupling between the couplers and ensuring operations at the designated operating frequency. Furthermore, the paper encompasses thermal and structural assessments conducted through numerical simulations.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    这项研究调查了散射箔材料和采样支架的放置如何影响来自用于FLASH放射治疗的改进型医用直线加速器的电子束中的电子能量分布。我们分析了电离室各个位置的电子能谱,镜子,和下巴-评估铜的影响,Pb-Cu,Pb,和Ta箔。我们的发现表明,靠近源增强了电子能量分布对箔材料的依赖性,通过材料选择实现精确的光束控制。蒙特卡罗模拟对于设计箔片以实现期望的能量分布是有效的。将采样支架移动到远离源的位置减少了箔材料的影响,促进更均匀的能量传播,特别是在0.5-10MeV范围内的12MeV电子束。这些见解强调了定制材料选择和采样支架定位在优化电子能量分布和通量强度方面的关键作用,用于FLASH放射治疗研究。有利于实验设计和临床应用。
    This study investigates how scattering foil materials and sampling holder placement affect electron energy distribution in electron beams from a modified medical linear accelerator for FLASH radiotherapy. We analyze electron energy spectra at various positions-ionization chamber, mirror, and jaw-to evaluate the impact of Cu, Pb-Cu, Pb, and Ta foils. Our findings show that close proximity to the source intensifies the dependence of electron energy distribution on foil material, enabling precise beam control through material selection. Monte Carlo simulations are effective for designing foils to achieve desired energy distributions. Moving the sampling holder farther from the source reduces foil material influence, promoting more uniform energy spreads, particularly in the 0.5-10 MeV range for 12 MeV electron beams. These insights emphasize the critical role of tailored material selection and sampling holder positioning in optimizing electron energy distribution and fluence intensity for FLASH radiotherapy research, benefiting both experimental design and clinical applications.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    立体定向放射外科(SRS)后放射诱发的变化(RIC)严重影响动静脉畸形(AVM)治疗的结局。本研究旨在确定RIC的预测因子,描述了RIC的类型和严重性,并评估其对患者功能结局的影响,以加强AVM患者的风险评估和治疗计划。
    这项回顾性研究分析了2015年1月至2020年12月在吉隆坡医院接受SRS的87例AVM患者。通过详细的磁共振成像评估确定RIC,和预测因素使用多元逻辑回归确定。使用改良的Rankin量表(mRS)评估功能结果。
    在队列中,40.2%已开发RIC,放射性RIC为33.3%,有症状的RIC为5.7%,永久RIC为1.1%。严重性分类显示25.3%为一级,13.8%为二级,1.1%为三级。值得注意的是,较高的Pollock-Flickinger评分和口才位置是RIC发生的重要预测因子。SRS后的功能结果有显著改善,非良好的mRS评分从SRS前的8.0%明显降低至SRS后的1.1%(P=0.031)。
    该研究确定了口才位置和Pollock-Flickinger得分作为SRS后RIC的预测因子。SRS后不良mRS评分的显着降低强调了SRS在改善患者预后方面的功效。他们的结果强调了个性化治疗计划的重要性,专注于精确的策略,以优化AVM管理中的患者结果,减少不良反应,同时改善功能结果。
    UNASSIGNED: Radiation-induced changes (RICs) post-stereotactic radiosurgery (SRS) critically influence outcomes in arteriovenous malformation (AVM) treatments. This study aimed to identify predictors of RICs, described the types and severity of RICs, and assessed their impact on patient\'s functional outcomes to enhance risk assessment and treatment planning for AVM patients.
    UNASSIGNED: This retrospective study analyzed 87 AVM patients who underwent SRS at Hospital Kuala Lumpur between January 2015 and December 2020. RICs were identified through detailed magnetic resonance imaging evaluations, and predictive factors were determined using multiple logistic regression. Functional outcomes were assessed with the modified Rankin scale (mRS).
    UNASSIGNED: Among the cohort, 40.2% developed RICs, with radiological RICs in 33.3%, symptomatic RICs in 5.7%, and permanent RICs in 1.1%. Severity categorization revealed 25.3% as Grade I, 13.8% as Grade II, and 1.1% as Grade III. Notably, higher Pollock-Flickinger scores and eloquence location were significant predictors of RIC occurrence. There was a significant improvement in functional outcomes post-SRS, with a marked decrease in non-favorable mRS scores from 8.0% pre-SRS to 1.1% post-SRS (P = 0.031).
    UNASSIGNED: The study identified the eloquence location and Pollock-Flickinger scores as predictors of RICs post-SRS. The significant reduction in non-favorable mRS scores post-SRS underscores the efficacy of SRS in improving patient outcomes. Their results highlighted the importance of personalized treatment planning, focusing on precise strategies to optimize patient outcomes in AVM management, reducing adverse effects while improving functional outcomes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    暴露于高,轻微致死剂量或更高的电离辐射,有意或意外,导致各种器官受伤。目前,只有有限数量的安全和有效的辐射对策由美国食品和药物管理局批准的此类伤害。这些批准的药物仅对急性放射综合征的造血成分有效,并且必须仅在暴露事件后才能施用:目前,没有FDA批准的药物可以预防性使用。营养食品,γ-生育三烯酚(GT3)已被发现是这种暴露相关伤害的有前途的辐射防护剂,特别是那些造血性质的,当在啮齿动物或非人类灵长类动物中测试时。我们调查了由非致死水平(4.0Gy)引起的特定器官系统/组织中GT3的损伤性质和可能的保护作用,以及潜在的致命水平(5.8Gy)的电离辐射,作为全身或部分身体暴露递送。结果表明,最严重的,剂量依赖性损伤发生在具有强大自我更新能力的器官系统内(例如,淋巴造血和胃肠道系统),而在其他组织中(例如,肝脏,肾,肺)具有较少的自我更新能力,注意到的病理倾向于不那么明显,并且不太依赖于暴露剂量水平或所应用的暴露方案。预防性使用测试营养品,GT3,似乎限制了血液形成组织内辐射相关病理的程度,在某种程度上,在胃肠道的小肠内。没有明显的区别,全球身体保护模式与代理人的使用有关,尽管暗示了可能的辐射防护益处,不仅是通过减少特定器官系统内的明显损伤,但也通过注意到在选择GT3治疗的动物中缺乏早期的垂死性。
    Exposure to high, marginally lethal doses or higher of ionizing radiation, either intentional or accidental, results in injury to various organs. Currently, there is only a limited number of safe and effective radiation countermeasures approved by US Food and Drug Administration for such injuries. These approved agents are effective for only the hematopoietic component of the acute radiation syndrome and must be administered only after the exposure event: currently, there is no FDA-approved agent that can be used prophylactically. The nutraceutical, gamma-tocotrienol (GT3) has been found to be a promising radioprotector of such exposure-related injuries, especially those of a hematopoietic nature, when tested in either rodents or nonhuman primates. We investigated the nature of injuries and the possible protective effects of GT3 within select organ systems/tissues caused by both non-lethal level (4.0 Gy), as well as potentially lethal level (5.8 Gy) of ionizing radiation, delivered as total-body or partial-body exposure. Results indicated that the most severe, dose-dependent injuries occurred within those organ systems with strong self-renewing capacities (e.g., the lymphohematopoietic and gastrointestinal systems), while in other tissues (e.g., liver, kidney, lung) endowed with less self-renewal, the pathologies noted tended to be less pronounced and less dependent on the level of exposure dose or on the applied exposure regimen. The prophylactic use of the test nutraceutical, GT3, appeared to limit the extent of irradiation-associated pathology within blood forming tissues and, to some extent, within the small intestine of the gastrointestinal tract. No distinct, global pattern of bodily protection was noted with the agent\'s use, although a hint of a possible radioprotective benefit was suggested not only by a lessening of apparent injury within select organ systems, but also by way of noting the lack of early onset of moribundity within select GT3-treated animals.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    无框架图像引导放射外科(IGRS)是一种有效且无创的方法,可治疗对三叉神经痛(TN)的医疗管理无反应的患者。这项研究评估了无框IGRS在治疗难治性TN患者中的应用。
    我们对116例诊断为TN的患者的记录进行了回顾性审查,这些患者使用线性加速器(LINAC)进行了10年(2012年3月至2023年2月)的无框IGRS。所有患者的TN医疗管理失败。使用巴罗神经研究所(BNI)评分系统对面部疼痛进行评分。每位患者在无框IGRS之前和治疗后接受BNI评分。失败定义为在最后一次随访和/或在IGRS后接受抢救程序时的BNI评分IV-V。
    所有患者在无框IGRS之前的BNI评分为IV或V。所有116例IGRS患者的平均随访时间为44.1个月。大多数患者(81[69.8%])在无框IGRS之前没有接受过TN手术(微血管减压术[MVD]或根际切开术)或立体定向放射外科(SRS)。共有41例(35.3%)患者接受了抢救程序(MVD,根际切断术,或额外的IGRS)跟随无框IGRS。初始无框IGRS和救助程序之间的平均持续时间为20.1个月。在最后一次随访中,共有110例(94.8%)患者的BNI评分为I-III.无框IGRS术后无并发症报告。与患者的初始BNI相比,末次随访时的BNI评分较低(P<0.001)。与IGRS未失败的患者相比,IGRS失败的患者在最后一次随访中的BNI评分更高(2.8vs.2.5,P=0.05)。与疼痛难治的SRS患者相比,疼痛缓解患者的随访时间较短(38.0vs.55.1,P=0.005)。
    在这个庞大的医学难治性TN患者队列中,无框IGRS可在大多数患者中实现持久的疼痛控制,无任何毒性.
    UNASSIGNED: Frameless image-guided radiosurgery (IGRS) is an effective and non-invasive method of treating patients who are unresponsive to medical management for trigeminal neuralgia (TN). This study evaluated the use of frameless IGRS to treat patients with medically refractory TN.
    UNASSIGNED: We performed a retrospective review of records of 116 patients diagnosed with TN who underwent frameless IGRS using a linear accelerator (LINAC) over 10 years (March 2012-February 2023). All patients had failed medical management for TN. Facial pain was graded using the Barrow Neurological Institute (BNI) scoring system. Each patient received a BNI score before frameless IGRS and following treatment. Failure was defined as a BNI score IV-V at the last follow-up and/or undergoing a salvage procedure following IGRS.
    UNASSIGNED: All patients had a BNI score of either IV or V before the frameless IGRS. The mean follow-up duration for all 116 patients following IGRS was 44.1 months. Most patients (81 [69.8%]) had not undergone surgery (microvascular decompression [MVD] or rhizotomy) or stereotactic radiosurgery (SRS) for TN before frameless IGRS. A total of 41 (35.3%) patients underwent a salvage procedure (MVD, rhizotomy, or an additional IGRS) following frameless IGRS. The mean duration between the initial frameless IGRS and salvage procedure was 20.1 months. At the last follow-up, a total of 110 (94.8%) patients had a BNI score of I-III. No complications were reported after the frameless IGRS. The BNI score at the last follow-up was lower compared to the initial BNI for patients regardless of prior intervention (P < 0.001). Patients who failed IGRS had a higher BNI score at the last follow-up compared to those who did not fail IGRS (2.8 vs. 2.5, P = 0.05). Patients with pain relief had a shorter follow-up compared to those with pain refractory to SRS (38.0 vs. 55.1, P = 0.005).
    UNASSIGNED: In this large cohort of patients with medically refractory TN, frameless IGRS resulted in durable pain control in the majority of patients without any toxicity.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目标在这项研究中,我们概述了我们在颈静脉血管球瘤(GJT)的立体定向放射外科(SRS)中给予≥15Gy剂量的理由,同时确保避免与剂量>13Gy相关的面神经并发症.为了避免这种并发症,我们最初使用了伽玛刀完美(GK)系统(ElektaInstrumentAB,斯德哥尔摩,瑞典)在我们的机构,但遇到了与漫长的治疗时间和雕刻剂量以尽量减少剂量以节省面神经有关的挑战。作为一个潜在的解决方案,我们建议使用HyperArc(瓦里安医疗系统,帕洛阿尔托,CA),新开发的基于线性加速器(LINAC)的SRS的自动交付平台。HyperArc提供了使用多个弧和多叶准直器的更快治疗和更复杂的放射治疗剂量成形的潜力。方法回顾性分析9例应用HyperArc治疗的GJT患者。收集患者的人口统计学和治疗数据。此外,创建模拟GK治疗计划,并与HyperArc计划进行比较,以评估节省时间,PTV覆盖率,和计划质量。结果男1例,女8例,平均年龄为63.9岁,包括在内。治疗平均在29分钟内完成,达到95-100%的肿瘤,同时限制面神经<13Gy。使用我们的GK系统重新扫描的治疗只能达到92-99%的肿瘤覆盖率,同时尊重面神经约束。平均治疗时间为180分钟。两种模式均获得了可比的计划质量参数。结论HyperArc系统提供了高度雕刻的放疗剂量的定性令人满意和快速的治疗递送,以最大化肿瘤覆盖并最小化面神经并发症。
    Objectives In this study, we outline our rationale for delivering a dose of ≥15 Gy in stereotactic radiosurgery (SRS) of glomus jugulare tumor (GJT) while ensuring the avoidance of complications associated with doses >13 Gy to the facial nerve. To avoid such complications, we initially utilized the Gamma Knife Perfexion (GK) system (Elekta Instrument AB, Stockholm, Sweden) at our institution but encountered challenges related to lengthy treatment times and difficulty in sculpting doses to minimize doses to spare the facial nerve. As a potential solution, we propose the use of HyperArc (Varian Medical Systems, Palo Alto, CA), a newly developed automated delivery platform for linear accelerator (LINAC)-based SRS. HyperArc offers the potential for faster treatment and more complex shaping of the radiotherapy dose with multiple arcs and multi-leaf collimators. Methods We retrospectively reviewed nine cases of patients with GJT treated with HyperArc. Patients\' demographic and treatment data were collected. Additionally, simulated GK treatment plans were created and compared with HyperArc plans to assess time savings, PTV coverage, and plan quality. Results One male and eight female patients, with a mean age of 63.9 years, were included. Treatments were delivered on average in 29 minutes, achieving 95-100% of the tumor while limiting the facial nerve to <13 Gy. Treatments replanned using our GK system could achieve only 92-99% tumor coverage while respecting facial nerve constraints, with average treatment times of 180 minutes. Comparable plan quality parameters were attained with both modalities. Conclusions The HyperArc system provides a qualitatively satisfactory and rapid treatment delivery of a highly sculpted radiotherapy dose to maximize tumor coverage and minimize facial nerve complications.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    这项工作提出了一个生态,用于测量千格雷剂量范围内的电离辐射的柔性二维辐射变色剂量计。用硝基四氮唑蓝氯化物作为辐射敏感化合物对纤维素制成的棉机织物进行了体积改性。它的功能包括从淡黄色到紫褐色的暴露过程中的颜色变化和灵活性,使其能够适应各种形状。发现(i)剂量反应高达〜80kGy,(ii)它与1.1-73.1kGy/min的剂量率无关,(iii)可以使用平板扫描仪在2D中进行测量,(iv)可以使用均值滤波器对所获取的图像进行滤波,这提高了它的剂量分辨率,(v)对于过滤后的图像,剂量分辨率为-0.07至-0.4kGy,为-0.6至-75.7kGy,和(vi)可以区分两个线性剂量子范围:~0.6至~7.6kGy和~9.9至~62.0kGy。剂量计与平板扫描仪读取和使用专用软件包的数据处理相结合,构成了用于测量具有复杂形状的物体的剂量分布的综合系统。
    This work presents an ecological, flexible 2D radiochromic dosimeter for measuring ionizing radiation in the kilogray dose range. Cotton woven fabric made of cellulose was volume-modified with nitrotetrazolium blue chloride as a radiation-sensitive compound. Its features include a color change during exposure from yellowish to purple-brown and flexibility that allows it to adapt to various shapes. It was found that (i) the dose response is up to ~80 kGy, (ii) it is independent of the dose rate for 1.1-73.1 kGy/min, (iii) it can be measured in 2D using a flatbed scanner, (iv) the acquired images can be filtered using a mean filter, which improves its dose resolution, (v) the dose resolution is -0.07 to -0.4 kGy for ~0.6 to ~75.7 kGy for filtered images, and (vi) two linear dose subranges can be distinguished: ~0.6 to ~7.6 kGy and ~9.9 to ~62.0 kGy. The dosimeter combined with flatbed scanner reading and data processing using dedicated software packages constitutes a comprehensive system for measuring dose distributions for objects with complex shapes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号